• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Studies on 2-oxoquinoline derivatives as blood platelet aggregation inhibitors, IV. Synthesis and biological activity of the metabolites of 6-[4-(1-cyclohexyl-1H-5-tetrazolyl)butoxy]-2-oxo-1,2,3,4- tetrahydroquinoline (OPC-13013).

作者信息

Nishi T, Tabusa F, Tanaka T, Shimizu T, Nakagawa K

出版信息

Chem Pharm Bull (Tokyo). 1985 Mar;33(3):1140-7. doi: 10.1248/cpb.33.1140.

DOI:10.1248/cpb.33.1140
PMID:4028296
Abstract
摘要

相似文献

1
Studies on 2-oxoquinoline derivatives as blood platelet aggregation inhibitors, IV. Synthesis and biological activity of the metabolites of 6-[4-(1-cyclohexyl-1H-5-tetrazolyl)butoxy]-2-oxo-1,2,3,4- tetrahydroquinoline (OPC-13013).2-氧代喹啉衍生物作为血小板聚集抑制剂的研究，IV. 6-[4-(1-环己基-1H-5-四唑基)丁氧基]-2-氧代-1,2,3,4-四氢喹啉（OPC-13013）代谢物的合成及生物活性
Chem Pharm Bull (Tokyo). 1985 Mar;33(3):1140-7. doi: 10.1248/cpb.33.1140.
2
Effect of cilostazol on platelet aggregation and experimental thrombosis.西洛他唑对血小板聚集和实验性血栓形成的影响。
Arzneimittelforschung. 1985;35(7A):1144-9.
3
[Synthesis of 5-(3-aryloxypropyl)-1-cyclohexyltetrazoles and their inhibition of blood platelet aggregation].5-(3-芳氧基丙基)-1-环己基四唑的合成及其对血小板聚集的抑制作用
Yakugaku Zasshi. 1984 Feb;104(2):152-6. doi: 10.1248/yakushi1947.104.2_152.
4
Inhibition of platelet aggregation by moxalactam and free N-methylthiotetrazole.羟羧氧酰胺菌素和游离N-甲基硫代四氮唑对血小板聚集的抑制作用。
Clin Ther. 1989 Sep-Oct;11(5):640-51.
5
Potentiation of anti-platelet aggregating activity of cilostazol with vascular endothelial cells.
Thromb Res. 1990 Feb 15;57(4):617-23. doi: 10.1016/0049-3848(90)90079-r.
6
Antiaggregatory effect of oral cilostazol and recovery of platelet aggregability in patients with cerebrovascular disease.
Arzneimittelforschung. 1985;35(7A):1189-92.
7
Studies on 2-oxoquinoline derivatives as blood platelet aggregation inhibitors. II. 6-[3-(1-cyclohexyl-5-tetrazolyl)propoxy]-1,2-dihydro-2-oxoquinoline and related compounds.2-氧代喹啉衍生物作为血小板聚集抑制剂的研究。II. 6-[3-(1-环己基-5-四唑基)丙氧基]-1,2-二氢-2-氧代喹啉及相关化合物
Chem Pharm Bull (Tokyo). 1983 Apr;31(4):1151-7. doi: 10.1248/cpb.31.1151.
8
Studies on gastric antiulcer active agents. III. Synthesis of 1-substituted 4-(5-tetrazolyl)thio-1-butanones and related compounds.胃抗溃疡活性剂的研究。III. 1-取代-4-(5-四唑基)硫代-1-丁酮及相关化合物的合成。
Chem Pharm Bull (Tokyo). 1989 Apr;37(4):958-61. doi: 10.1248/cpb.37.958.
9
Clinical effects of oral cilostazol on suppression of platelet function in patients with cerebrovascular disease.
Arzneimittelforschung. 1985;35(7A):1186-8.
10
Studies on 2-oxoquinoline derivatives as blood platelet aggregation inhibitors. III. N-cyclohexyl-N-(2-hydroxyethyl)-4-(1,2-dihydro-2-oxo-6-quinolyloxy)-butyramide and related compounds.2-氧代喹啉衍生物作为血小板聚集抑制剂的研究。III. N-环己基-N-(2-羟乙基)-4-(1,2-二氢-2-氧代-6-喹啉氧基)丁酰胺及相关化合物。
Chem Pharm Bull (Tokyo). 1983 Mar;31(3):852-60. doi: 10.1248/cpb.31.852.

引用本文的文献

1
The pharmacokinetic and pharmacodynamic interaction of clopidogrel and cilostazol in relation to CYP2C19 and CYP3A5 genotypes.氯吡格雷与西洛他唑在CYP2C19和CYP3A5基因分型方面的药代动力学和药效学相互作用。
Br J Clin Pharmacol. 2016 Feb;81(2):301-12. doi: 10.1111/bcp.12794. Epub 2015 Dec 28.